Projects per year
Personal profile
Education
- 2009-2019 Ph.D., Graduate Institute of Clinical Medical Sciences, Chang Gung University
- 1994-2001 M.D., School of Medicine, College of Medicine, Taipei Medical University
Experience
- 2020.07- Assistant Professor, Department of Surgery, School of Medicine, Taipei Medical University
- 2019.10- Visiting Staff, Taipei Medical University Hospital
- 2010-2019 Visiting Staff, Division of Neurosurgery, Taipei Municipal Wanfang Hospital
- 2001-2010 Visiting Staff/Resident, Division of Neurosurgery, Chang Gung Memorial Hospital
Research Interests
- Neurosurgery
- Neuro-oncology
- Brain tumor
URL
Fingerprint Dive into the research topics where ShuMei Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 22 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 1 Active
熱休克蛋白在抗藥性髓母細胞瘤及腫瘤幹細胞中的角色
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
Research Output
Targeting inhibitors of apoptosis proteins suppresses medulloblastoma cell proliferation via G2/M phase arrest and attenuated neddylation of p21
Chen, S. M., Lin, T. K., Tseng, Y. Y., Tu, C. H., Lui, T. N., Huang, S. F., Hsieh, L. L. & Li, Y. Y., Aug 2018, In : Cancer Medicine. 7, 8, p. 3988-4003 16 p.Research output: Contribution to journal › Article
1
Citation
(Scopus)
Autophagic mechanism in anti-cancer immunity: Its pros and cons for cancer therapy
Li, Y. Y., Feun, L. G., Thongkum, A., Tu, C. H., Chen, S. M., Wangpaichitr, M., Wu, C., Kuo, M. T. & Savaraj, N., Jun 19 2017, In : International Journal of Molecular Sciences. 18, 6, 1297.Research output: Contribution to journal › Review article
Open Access
11
Citations
(Scopus)
Degradation of AMPK-α1 sensitizes BRAF inhibitor-resistant melanoma cells to arginine deprivation
Li, Y. Y., Wu, C., Shah, S. S., Chen, S. M., Wangpaichitr, M., Kuo, M. T., Feun, L. G., Han, X., Suarez, M., Prince, J. & Savaraj, N., Dec 1 2017, In : Molecular Oncology. 11, 12, p. 1806-1825 20 p.Research output: Contribution to journal › Article
Open Access
3
Citations
(Scopus)
Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer
Wangpaichitr, M., Wu, C., Li, Y. Y., Nguyen, D. J. M., Kandemir, H., Shah, S., Chen, S., Feun, L. G., Prince, J. S., Kuo, M. T. & Savaraj, N., Jan 1 2017, In : Oncotarget. 8, 30, p. 49275-49292 18 p.Research output: Contribution to journal › Article
22
Citations
(Scopus)
Blockade of inhibitors of apoptosis proteins in combination with conventional chemotherapy leads to synergistic antitumor activity in medulloblastoma and cancer stem-like cells
Chen, S. M., Li, Y. Y., Tu, C. H., Salazar, N., Tseng, Y. Y., Huang, S. F., Hsieh, L. L. & Lui, T. N., Aug 1 2016, In : PLoS One. 11, 8, e0161299.Research output: Contribution to journal › Article
10
Citations
(Scopus)